Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07217457

Epidural Wave Form Analysis vs Fluoroscopic Guidance for Thoracic Epidural Placement

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
160 (estimated)
Sponsor
Dartmouth-Hitchcock Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to compare the effectiveness of epidural waveform analysis (EWA) with fluoroscopic guidance for confirmation of successful epidural placement. In this study, participants will undergo both EWA and fluoroscopy. EWA involves measuring the pressure in the epidural space once accessed and determining whether or not a waveform that corresponds with the participant's heart rate is present. The pressure measuring apparatus is the same that is used for direct pressure monitoring elsewhere in the body (i.e. invasive arterial catheters or intracranial pressure monitoring).

Detailed description

The primary objective of this study is to assess the accuracy with which epidural waveform analysis (EWA) can confirm epidural access in comparison to the gold standard of fluoroscopic confirmation (FC). Our hypothesis is that FC is superior to EWA. We will determine the Positive Predictive Value and Negative Predictive Value of EWA referenced to FC. If EWA performs reasonably well compared to FC, then EWA could be used in settings where anesthesia providers do not have access to fluoroscopy or the expertise to perform fluoroscopic-guided thoracic epidurals. EWA uses clinically approved pressure transducers, which are used commonly to analyze other physiologic pressures (e.g. invasive hemodynamic monitoring and invasive intracranial pressure monitoring.) and could offer a low budget way to help reassure that placement of a needle is indeed epidural, and not in a different location.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTEpidural Waveform AnalysisAll participants in this study will undergo epidural waveform analysis (pressure measurements) and fluoroscopic guidance of epidural placement. Epidural waveform analysis as method to determine epidural access will be compared to fluoroscopic confirmation.

Timeline

Start date
2025-09-12
Primary completion
2026-08-31
Completion
2026-12-31
First posted
2025-10-16
Last updated
2025-10-16

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT07217457. Inclusion in this directory is not an endorsement.